Vitamin D: clinical trials recruiting now
8
Recruiting trials
15
Conditions studied
1
US states with sites
5
Countries
FDA drug label
- FDA-approved
- Yes. Vitamin D appears in the FDA drug-label database. Marketed as Vitamin D.
- Drug class
- Provitamin D2 Compound (FDA established pharmacologic class)
FDA-approved use
Ergocalciferol is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.
Phase breakdown
Phase 1 1
Phase 2 1
Phase 4 1
Not applicable 5
Conditions being studied
Recruiting trials involving Vitamin D
- Effect of Vitamin D on Ovulation Rate in Women With Polycystic Ovary Syndrome
- Effect of Vitamin D3 Supplementation on Cardiac Autonomic Nerve Function in Male Epileptic Patients With Hypovitaminosis D
- Effect of Vitamin D3 Supplementation on Cardiac Autonomic Nerve Function in Male Parkinson's Disease Patients With Hypovitaminosis D
- Effects of Mega-dose Vitamin D Pulse and Maintenance Therapy on Seizure Frequency, Fatigue, and Quality of Life: A Prospective Study
- Efficacy of Injectable Vitamin D Supplementation in Females With Polycystic Ovary Syndrome
- Maternal Stress on Human Milk and Infant Outcomes
- Vitamin D and Polycystic Ovarian Syndrome (PCOS)
- Vitamin D for Preventing Recurrent Preeclampsia in Pregnant Women
Common questions
Is Vitamin D FDA-approved?
Yes, marketed as Vitamin D.
How many recruiting trials involve Vitamin D?
8 recruiting trials across 15 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.